DavidI.RosenthalMDFACR, FASTRO

Radiation Oncology • Houston, TX

Head & Neck

Professor, HN Section Chief

Join to view full profile

Dr. Rosenthal is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Rosenthal's full profile

Already have an account?

Office
1515 Holcombe Blvd
Houston, TX 77030
Phone+1 713-792-6161

Education & Training

University of North Carolina HospitalsResidency, Radiation Oncology, 1988 - 1991
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Radiology-Diagnostic, 1987 - 1988
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Otolaryngology - Head and Neck Surgery, 1985 - 1987
University of Miami/Jackson Health SystemInternship, Transitional Year, 1984 - 1985
University of Miami Leonard M. Miller School of MedicineClass of 1984

Certifications & Licensure

OH State Medical License 1986 - 2026
TX State Medical License 1992 - 2026
AZ State Medical License 2023 - 2025
FL State Medical License 1988 - 2025
MS State Medical License 2023 - 2025
NC State Medical License 1988 - 2025
OK State Medical License 2020 - 2025
WA State Medical License 2023 - 2025
AL State Medical License 2023 - 2024
GA State Medical License 2023 - 2024
LA State Medical License 2023 - 2024
TN State Medical License 2023 - 2024
NJ State Medical License 1999 - 2007
PA State Medical License 1996 - 2006
American Board of Radiology Radiation Oncology
Join now to see all

Clinical Trials

Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Gastric Cancer Start of enrollment: 1999 Jun 01
Completed
Phase 2
Palifermin in Lessening Oral Mucositis in Patients Undergoing Radiation Therapy and Chemotherapy for Locally Advanced Head and Neck Cancer Start of enrollment: 2006 Jul 01
Terminated
Phase 3
Caphosol for the Reduction of Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer Start of enrollment: 2009 May 01
Unknown status
Phase 1, Phase 2
Reflux Disease in Head and Neck Cancer Patients Undergoing Radiation Therapy Start of enrollment: 2012 Nov 01
Withdrawn
Not Applicable
Symptom Burden in Head and Neck Cancer Start of enrollment: 2013 Mar 01
Terminated
Phase 1, Phase 2
Phase II Randomized-registry Embedded Study of Lymphoscintigraphy for Oropharyngeal Neoplasms to Enable Risk-adapted Nodal Guidance for Robotic Surgery and/or Radiotherapy (LONE-RANGR2) Start of enrollment: 2024 Apr 19
Recruiting
Phase 2
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

26 citations
Dynamic contrast-enhanced MRI detects acute radiotherapy-induced alterations in mandibular microvasculature: prospective assessment of imaging biomarkers of normal tis...
Vlad C. Sandulache, Brian P. Hobbs, R. Abdallah S Mohamed, Steven J. Frank, Juhee Song
Scientific Reports. 2016-08-08
35 citations
Predicting two-year longitudinal MD Anderson Dysphagia Inventory outcomes after intensity modulated radiotherapy for locoregionally advanced oropharyngeal carcinoma.
Ryan P. Goepfert, Jan S. Lewin, Martha P. Barrow, C. David Fuller, Stephen Y. Lai
The Laryngoscope. 2017-04-01
57 citations
Dose-volume correlates of mandibular osteoradionecrosis in Oropharynx cancer patients receiving intensity-modulated radiotherapy: Results from a case-matched comparison
Abdallah S.R. Mohamed, Brian P. Hobbs, Katherine A. Hutcheson, Michael S. Murri, Naveen Garg
Radiotherapy and Oncology. 2017-08-01